![JU8 JU8](https://data.pdbj.org/pdbjplus/data/cc/svg/JU8.svg) | JU8 | Name: | 5-(1-methylindol-3-yl)pyrimidin-4-amine | Formula: | C13 H12 N4 | SMILES: | Cn1cc(c2cncnc2N)c3ccccc13 | InChi: | InChI=1S/C13H12N4/c1-17-7-11(9-4-2-3-5-12(9)17)10-6-15-8-16-13(10)14/h2-8H,1H3,(H2,14,15,16) | Definition date: | 2019-03-28 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 5-(1-methylindol-3-yl)pyrimidin-4-amine |
|
![CU0 CU0](https://data.pdbj.org/pdbjplus/data/cc/svg/CU0.svg) | CU0 | Name: | [(2~{R},3~{S},4~{S})-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphono hydrogen phosphate | Formula: | C5 H12 O10 P2 | SMILES: | O[CH]1CO[CH](CO[P](O)(=O)O[P](O)(O)=O)[CH]1O | InChi: | InChI=1S/C5H12O10P2/c6-3-1-13-4(5(3)7)2-14-17(11,12)15-16(8,9)10/h3-7H,1-2H2,(H,11,12)(H2,8,9,10)/t3-,4+,5-/m0/s1 | Definition date: | 2019-05-15 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | [(2~{R},3~{S},4~{S})-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphono hydrogen phosphate |
|
![CUU CUU](https://data.pdbj.org/pdbjplus/data/cc/svg/CUU.svg) | CUU | Name: | [(2~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-oxolan-2-yl]methyl phosphono hydrogen phosphate | Formula: | C10 H15 N5 O9 P2 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[P](O)(O)=O)C[CH]3O | InChi: | InChI=1S/C10H15N5O9P2/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(16)1-5(23-10)2-22-26(20,21)24-25(17,18)19/h3-6,10,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/t5-,6+,10+/m0/s1 | Definition date: | 2019-05-15 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | [(2~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-oxolan-2-yl]methyl phosphono hydrogen phosphate |
|
![N7A N7A](https://data.pdbj.org/pdbjplus/data/cc/svg/N7A.svg) | N7A | Name: | 4-{[(4-hydroxybutyl)carbamoyl]amino}benzene-1-sulfonamide | Formula: | C11 H17 N3 O4 S | SMILES: | c1cc(S(=O)(=O)N)ccc1NC(=O)NCCCCO | InChi: | InChI=1S/C11H17N3O4S/c12-19(17,18)10-5-3-9(4-6-10)14-11(16)13-7-1-2-8-15/h3-6,15H,1-2,7-8H2,(H2,12,17,18)(H2,13,14,16) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 4-{[(4-hydroxybutyl)carbamoyl]amino}benzene-1-sulfonamide |
|
![N7D N7D](https://data.pdbj.org/pdbjplus/data/cc/svg/N7D.svg) | N7D | Name: | 3-{[(4-hydroxybutyl)carbamoyl]amino}benzene-1-sulfonamide | Formula: | C11 H17 N3 O4 S | SMILES: | OCCCCNC(Nc1cc(ccc1)S(=O)(=O)N)=O | InChi: | InChI=1S/C11H17N3O4S/c12-19(17,18)10-5-3-4-9(8-10)14-11(16)13-6-1-2-7-15/h3-5,8,15H,1-2,6-7H2,(H2,12,17,18)(H2,13,14,16) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-{[(4-hydroxybutyl)carbamoyl]amino}benzene-1-sulfonamide |
|
![N7J N7J](https://data.pdbj.org/pdbjplus/data/cc/svg/N7J.svg) | N7J | Name: | (2Z)-2-(hydroxyimino)-2,3-dihydro-1,3-benzoxazole-5-sulfonamide | Formula: | C7 H7 N3 O4 S | SMILES: | c1c(ccc2c1N/C(O2)=N/O)S(=O)(=O)N | InChi: | InChI=1S/C7H7N3O4S/c8-15(12,13)4-1-2-6-5(3-4)9-7(10-11)14-6/h1-3,11H,(H,9,10)(H2,8,12,13) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | (2Z)-2-(hydroxyimino)-2,3-dihydro-1,3-benzoxazole-5-sulfonamide |
|
![N7M N7M](https://data.pdbj.org/pdbjplus/data/cc/svg/N7M.svg) | N7M | Name: | 4-{[(2-hydroxyethyl)carbamoyl]amino}benzene-1-sulfonamide | Formula: | C9 H13 N3 O4 S | SMILES: | c1cc(S(=O)(=O)N)ccc1NC(=O)NCCO | InChi: | InChI=1S/C9H13N3O4S/c10-17(15,16)8-3-1-7(2-4-8)12-9(14)11-5-6-13/h1-4,13H,5-6H2,(H2,10,15,16)(H2,11,12,14) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 4-{[(2-hydroxyethyl)carbamoyl]amino}benzene-1-sulfonamide |
|
![N7S N7S](https://data.pdbj.org/pdbjplus/data/cc/svg/N7S.svg) | N7S | Name: | 4-hydroxy-3-{[(4-hydroxybutyl)carbamoyl]amino}benzene-1-sulfonamide | Formula: | C11 H17 N3 O5 S | SMILES: | c1cc(cc(c1O)NC(NCCCCO)=O)S(N)(=O)=O | InChi: | InChI=1S/C11H17N3O5S/c12-20(18,19)8-3-4-10(16)9(7-8)14-11(17)13-5-1-2-6-15/h3-4,7,15-16H,1-2,5-6H2,(H2,12,18,19)(H2,13,14,17) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 4-hydroxy-3-{[(4-hydroxybutyl)carbamoyl]amino}benzene-1-sulfonamide |
|
![N7V N7V](https://data.pdbj.org/pdbjplus/data/cc/svg/N7V.svg) | N7V | Name: | 3-[(1S)-1-(4-nitrophenyl)ethyl]-2-oxo-2,3-dihydro-1,3-benzoxazole-5-sulfonamide | Formula: | C15 H13 N3 O6 S | SMILES: | c12c(ccc(c1)S(=O)(=O)N)OC(N2C(c3ccc(cc3)[N+]([O-])=O)C)=O | InChi: | InChI=1S/C15H13N3O6S/c1-9(10-2-4-11(5-3-10)18(20)21)17-13-8-12(25(16,22)23)6-7-14(13)24-15(17)19/h2-9H,1H3,(H2,16,22,23)/t9-/m0/s1 | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[(1S)-1-(4-nitrophenyl)ethyl]-2-oxo-2,3-dihydro-1,3-benzoxazole-5-sulfonamide |
|
![N84 N84](https://data.pdbj.org/pdbjplus/data/cc/svg/N84.svg) | N84 | Name: | 4-hydroxy-3-({[(pyridin-4-yl)methyl]carbamoyl}amino)benzene-1-sulfonamide | Formula: | C13 H14 N4 O4 S | SMILES: | c1cc(cc(c1O)NC(NCc2ccncc2)=O)S(N)(=O)=O | InChi: | InChI=1S/C13H14N4O4S/c14-22(20,21)10-1-2-12(18)11(7-10)17-13(19)16-8-9-3-5-15-6-4-9/h1-7,18H,8H2,(H2,14,20,21)(H2,16,17,19) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 4-hydroxy-3-({[(pyridin-4-yl)methyl]carbamoyl}amino)benzene-1-sulfonamide |
|
![N8A N8A](https://data.pdbj.org/pdbjplus/data/cc/svg/N8A.svg) | N8A | Name: | 4-hydroxy-3-({[2-(pyridin-2-yl)ethyl]carbamoyl}amino)benzene-1-sulfonamide | Formula: | C14 H16 N4 O4 S | SMILES: | c1cccnc1CCNC(Nc2cc(ccc2O)S(=O)(=O)N)=O | InChi: | InChI=1S/C14H16N4O4S/c15-23(21,22)11-4-5-13(19)12(9-11)18-14(20)17-8-6-10-3-1-2-7-16-10/h1-5,7,9,19H,6,8H2,(H2,15,21,22)(H2,17,18,20) | Definition date: | 2019-05-06 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 4-hydroxy-3-({[2-(pyridin-2-yl)ethyl]carbamoyl}amino)benzene-1-sulfonamide |
|
![ONY ONY](https://data.pdbj.org/pdbjplus/data/cc/svg/ONY.svg) | ONY | Name: | 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-methyl-N-[2-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide | Formula: | C22 H22 N4 O3 | SMILES: | CN(CCc1noc(n1)C)C(=O)Cc2ccc(cc2)Oc3cc(c(cc3)C#N)C | InChi: | InChI=1S/C22H22N4O3/c1-15-12-20(9-6-18(15)14-23)28-19-7-4-17(5-8-19)13-22(27)26(3)11-10-21-24-16(2)29-25-21/h4-9,12H,10-11,13H2,1-3H3 | Definition date: | 2019-07-01 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-methyl-N-[2-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide |
|
![DYF DYF](https://data.pdbj.org/pdbjplus/data/cc/svg/DYF.svg) | DYF | Name: | [(3~{R})-2,2-dimethyl-4-[[3-[2-[[(~{E})-oct-2-enoyl]amino]ethylamino]-3-oxidanylidene-propyl]amino]-3-oxidanyl-4-oxidanylidene-butyl] dihydrogen phosphate | Formula: | C19 H36 N3 O8 P | SMILES: | CCCCCC=CC(=O)NCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(O)=O | InChi: | InChI=1S/C19H36N3O8P/c1-4-5-6-7-8-9-15(23)20-12-13-21-16(24)10-11-22-18(26)17(25)19(2,3)14-30-31(27,28)29/h8-9,17,25H,4-7,10-14H2,1-3H3,(H,20,23)(H,21,24)(H,22,26)(H2,27,28,29)/b9-8+/t17-/m0/s1 | Definition date: | 2019-09-19 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | [(3~{R})-2,2-dimethyl-4-[[3-[2-[[(~{E})-oct-2-enoyl]amino]ethylamino]-3-oxidanylidene-propyl]amino]-3-oxidanyl-4-oxidanylidene-butyl] dihydrogen phosphate |
|
![QFY QFY](https://data.pdbj.org/pdbjplus/data/cc/svg/QFY.svg) | QFY | Name: | {N-(2-{bis[(pyridin-2-yl-kappaN)methyl]amino-kappaN}ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide}iron(3+) | Formula: | C24 H32 Fe N6 O2 S | SMILES: | C12NC(=O)NC1CSC2CCCCC(NCC[N+]43Cc6[n+]([Fe]3[n+]5c(C4)cccc5)cccc6)=O | InChi: | InChI=1S/C24H32N6O2S.Fe/c31-22(10-2-1-9-21-23-20(17-33-21)28-24(32)29-23)27-13-14-30(15-18-7-3-5-11-25-18)16-19-8-4-6-12-26-19 | Definition date: | 2019-10-25 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | {N-(2-{bis[(pyridin-2-yl-kappaN)methyl]amino-kappaN}ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide}iron(3+) |
|
![QG1 QG1](https://data.pdbj.org/pdbjplus/data/cc/svg/QG1.svg) | QG1 | Name: | {5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-(2-{[(pyridin-2-yl)methyl][(pyridin-2-yl-kappaN)methyl]amino-kappaN}ethyl)pentanamide}iron(2+) | Formula: | C24 H32 Fe N6 O2 S | SMILES: | C12NC(=O)NC1CSC2CCCCC(NCC[N+]5(Cc3ncccc3)Cc4cccc[n+]4[Fe]5)=O | InChi: | InChI=1S/C24H32N6O2S.Fe/c31-22(10-2-1-9-21-23-20(17-33-21)28-24(32)29-23)27-13-14-30(15-18-7-3-5-11-25-18)16-19-8-4-6-12-26-19 | Definition date: | 2019-10-25 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | {5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-(2-{[(pyridin-2-yl)methyl][(pyridin-2-yl-kappaN)methyl]amino-kappaN}ethyl)pentanamide}iron(2+) |
|
![QG4 QG4](https://data.pdbj.org/pdbjplus/data/cc/svg/QG4.svg) | QG4 | Name: | {N-(2-{bis[(pyridin-2-yl-kappaN)methyl]amino-kappaN}ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide}(triaza-1,2-dien-2-ium-1-ide-kappaN~1~)iron(4+) | Formula: | C24 H33 Fe N9 O2 S | SMILES: | O=C1NC2C(N1)C(SC2)CCCCC(NCC[N+]43Cc6[n+]([Fe]3([n+]5c(C4)cccc5)N=[N+]=N)cccc6)=O | InChi: | InChI=1S/C24H32N6O2S.Fe.HN3/c31-22(10-2-1-9-21-23-20(17-33-21)28-24(32)29-23)27-13-14-30(15-18-7-3-5-11-25-18)16-19-8-4-6-12-26-19 | Definition date: | 2019-10-25 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | {N-(2-{bis[(pyridin-2-yl-kappaN)methyl]amino-kappaN}ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide}(triaza-1,2-dien-2-ium-1-ide-kappaN~1~)iron(4+) |
|
![QG7 QG7](https://data.pdbj.org/pdbjplus/data/cc/svg/QG7.svg) | QG7 | Name: | N-(2-{bis[(pyridin-2-yl)methyl]amino}ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide | Formula: | C24 H32 N6 O2 S | SMILES: | C12C(NC(=O)N1)CSC2CCCCC(NCCN(Cc3ncccc3)Cc4ccccn4)=O | InChi: | InChI=1S/C24H32N6O2S/c31-22(10-2-1-9-21-23-20(17-33-21)28-24(32)29-23)27-13-14-30(15-18-7-3-5-11-25-18)16-19-8-4-6-12-26-19/h3-8,11-12,20-21,23H,1-2,9-10,13-17H2,(H,27,31)(H2,28,29,32)/t20-,21-,23-/m0/s1 | Definition date: | 2019-10-25 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | N-(2-{bis[(pyridin-2-yl)methyl]amino}ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide |
|
![QHY QHY](https://data.pdbj.org/pdbjplus/data/cc/svg/QHY.svg) | QHY | Name: | 1-{4-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}piperidine-4-carboxylic acid | Formula: | C21 H28 N6 O3 | SMILES: | c1cc(c(cc1)N2CCN(CC2)c3ncnc(n3)N4CCC(CC4)C(O)=O)OCC | InChi: | InChI=1S/C21H28N6O3/c1-2-30-18-6-4-3-5-17(18)25-11-13-27(14-12-25)21-23-15-22-20(24-21)26-9-7-16(8-10-26)19(28)29/h3-6,15-16H,2,7-14H2,1H3,(H,28,29) | Definition date: | 2019-11-04 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 1-{4-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}piperidine-4-carboxylic acid |
|
![HWQ HWQ](https://data.pdbj.org/pdbjplus/data/cc/svg/HWQ.svg) | HWQ | Name: | 3-[methyl-[2-[methyl(piperidin-4-yl)amino]thieno[3,2-d]pyrimidin-4-yl]amino]propanenitrile | Formula: | C16 H22 N6 S | SMILES: | CN(CCC#N)c1nc(nc2ccsc12)N(C)C3CCNCC3 | InChi: | InChI=1S/C16H22N6S/c1-21(10-3-7-17)15-14-13(6-11-23-14)19-16(20-15)22(2)12-4-8-18-9-5-12/h6,11-12,18H,3-5,8-10H2,1-2H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[methyl-[2-[methyl(piperidin-4-yl)amino]thieno[3,2-d]pyrimidin-4-yl]amino]propanenitrile |
|
![HWT HWT](https://data.pdbj.org/pdbjplus/data/cc/svg/HWT.svg) | HWT | Name: | 3-[[2-[3-(dimethylamino)propyl-methyl-amino]thieno[3,2-d]pyrimidin-4-yl]-methyl-amino]propanenitrile | Formula: | C16 H24 N6 S | SMILES: | CN(C)CCCN(C)c1nc2ccsc2c(n1)N(C)CCC#N | InChi: | InChI=1S/C16H24N6S/c1-20(2)9-6-11-22(4)16-18-13-7-12-23-14(13)15(19-16)21(3)10-5-8-17/h7,12H,5-6,9-11H2,1-4H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[[2-[3-(dimethylamino)propyl-methyl-amino]thieno[3,2-d]pyrimidin-4-yl]-methyl-amino]propanenitrile |
|
![HWW HWW](https://data.pdbj.org/pdbjplus/data/cc/svg/HWW.svg) | HWW | Name: | 3-[[6-~{tert}-butyl-2-[3-(dimethylamino)propyl-methyl-amino]thieno[3,2-d]pyrimidin-4-yl]-methyl-amino]propanenitrile | Formula: | C20 H32 N6 S | SMILES: | CN(C)CCCN(C)c1nc2cc(sc2c(n1)N(C)CCC#N)C(C)(C)C | InChi: | InChI=1S/C20H32N6S/c1-20(2,3)16-14-15-17(27-16)18(25(6)12-8-10-21)23-19(22-15)26(7)13-9-11-24(4)5/h14H,8-9,11-13H2,1-7H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[[6-~{tert}-butyl-2-[3-(dimethylamino)propyl-methyl-amino]thieno[3,2-d]pyrimidin-4-yl]-methyl-amino]propanenitrile |
|
![HWZ HWZ](https://data.pdbj.org/pdbjplus/data/cc/svg/HWZ.svg) | HWZ | Name: | 3-[methyl-[2-[methyl-(1-methylpiperidin-4-yl)amino]quinazolin-4-yl]amino]propanenitrile | Formula: | C19 H26 N6 | SMILES: | CN1CCC(CC1)N(C)c2nc3ccccc3c(n2)N(C)CCC#N | InChi: | InChI=1S/C19H26N6/c1-23-13-9-15(10-14-23)25(3)19-21-17-8-5-4-7-16(17)18(22-19)24(2)12-6-11-20/h4-5,7-8,15H,6,9-10,12-14H2,1-3H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[methyl-[2-[methyl-(1-methylpiperidin-4-yl)amino]quinazolin-4-yl]amino]propanenitrile |
|
![HXE HXE](https://data.pdbj.org/pdbjplus/data/cc/svg/HXE.svg) | HXE | Name: | 3-[[2-[(1-ethylpiperidin-4-yl)-methyl-amino]thieno[3,2-d]pyrimidin-4-yl]-methyl-amino]propanenitrile | Formula: | C18 H26 N6 S | SMILES: | CCN1CCC(CC1)N(C)c2nc3ccsc3c(n2)N(C)CCC#N | InChi: | InChI=1S/C18H26N6S/c1-4-24-11-6-14(7-12-24)23(3)18-20-15-8-13-25-16(15)17(21-18)22(2)10-5-9-19/h8,13-14H,4-7,10-12H2,1-3H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[[2-[(1-ethylpiperidin-4-yl)-methyl-amino]thieno[3,2-d]pyrimidin-4-yl]-methyl-amino]propanenitrile |
|
![HXN HXN](https://data.pdbj.org/pdbjplus/data/cc/svg/HXN.svg) | HXN | Name: | 3-[[6-bromanyl-2-[3-(dimethylamino)propyl-methyl-amino]quinazolin-4-yl]-methyl-amino]propanenitrile | Formula: | C18 H25 Br N6 | SMILES: | CN(C)CCCN(C)c1nc2ccc(Br)cc2c(n1)N(C)CCC#N | InChi: | InChI=1S/C18H25BrN6/c1-23(2)10-6-12-25(4)18-21-16-8-7-14(19)13-15(16)17(22-18)24(3)11-5-9-20/h7-8,13H,5-6,10-12H2,1-4H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 3-[[6-bromanyl-2-[3-(dimethylamino)propyl-methyl-amino]quinazolin-4-yl]-methyl-amino]propanenitrile |
|
![HXQ HXQ](https://data.pdbj.org/pdbjplus/data/cc/svg/HXQ.svg) | HXQ | Name: | 4-[ethyl(methyl)amino]-2-[methyl-(1-methylpiperidin-4-yl)amino]-~{N}-(1,3,5-trimethylpyrazol-4-yl)quinazoline-6-sulfonamide | Formula: | C24 H36 N8 O2 S | SMILES: | CCN(C)c1nc(nc2ccc(cc12)[S](=O)(=O)Nc3c(C)nn(C)c3C)N(C)C4CCN(C)CC4 | InChi: | InChI=1S/C24H36N8O2S/c1-8-30(5)23-20-15-19(35(33,34)28-22-16(2)27-32(7)17(22)3)9-10-21(20)25-24(26-23)31(6)18-11-13-29(4)14-12-18/h9-10,15,18,28H,8,11-14H2,1-7H3 | Definition date: | 2019-01-02 | Last modified: | 2020-05-01 | Release date: | 2020-05-06 | Identifier: | 4-[ethyl(methyl)amino]-2-[methyl-(1-methylpiperidin-4-yl)amino]-~{N}-(1,3,5-trimethylpyrazol-4-yl)quinazoline-6-sulfonamide |
|